ifosfamide has been researched along with B16 Melanoma in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The series of 9 compounds, including 3 racemates and 6 enantiomers of bromine-substituted analogues of ifosfamide (bromo-, chlorobromo- and dibromofosfamides) have been evaluated for antitumor activity against L1210 leukemia, Lewis lung carcinoma and B16 melanoma in mice." | 3.68 | Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds. ( Glazman-Kuśnierczyk, H; Matuszyk, J; Radzikowski, C, 1992) |
| "Three murine tumor lines, B16 melanoma, C38 colon cancer and M2661 breast cancer, were used to evaluate the therapeutic efficacy of the drug combination ACNU and ifosfamide." | 3.68 | Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer. ( Nooter, K; Silbermann, MH; Stoter, G; vd Vecht, B; Verweij, J, 1990) |
| " The seven agents combined with CI-973 were mitomycin C, cyclophosphamide, doxorubicin, vinblastine, etoposide, ifosfamide, and methotrexate." | 1.29 | Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. ( Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siurala, M | 1 |
| Bramante, S | 1 |
| Vassilev, L | 1 |
| Hirvinen, M | 1 |
| Parviainen, S | 1 |
| Tähtinen, S | 1 |
| Guse, K | 1 |
| Cerullo, V | 1 |
| Kanerva, A | 1 |
| Kipar, A | 1 |
| Vähä-Koskela, M | 1 |
| Hemminki, A | 1 |
| Hirabayashi, K | 1 |
| Okada, E | 1 |
| Elliott, WL | 1 |
| Roberts, BJ | 1 |
| Howard, CT | 1 |
| Leopold, WR | 1 |
| Misiura, K | 1 |
| Kinas, RW | 1 |
| Kuśnierczyk, H | 1 |
| Radzikowski, C | 2 |
| Stec, WJ | 1 |
| Glazman-Kuśnierczyk, H | 1 |
| Matuszyk, J | 1 |
| Silbermann, MH | 1 |
| vd Vecht, B | 1 |
| Stoter, G | 1 |
| Nooter, K | 1 |
| Verweij, J | 1 |
1 trial available for ifosfamide and B16 Melanoma
| Article | Year |
|---|---|
Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1993 |
5 other studies available for ifosfamide and B16 Melanoma
| Article | Year |
|---|---|
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.
Topics: Adenoviridae; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Combined Modali | 2015 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosph | 1994 |
(S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Biological Availability; Carcinoma, Lewis Lung; Chromato | 2001 |
Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
Topics: Animals; Bromine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ifosfamide; Le | 1992 |
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Synergism; Ifosfami | 1990 |